17.79
Schlusskurs vom Vortag:
$17.52
Offen:
$17.54
24-Stunden-Volumen:
2.37M
Relative Volume:
1.61
Marktkapitalisierung:
$1.53B
Einnahmen:
$1.13B
Nettoeinkommen (Verlust:
$62.75M
KGV:
28.24
EPS:
0.63
Netto-Cashflow:
$170.92M
1W Leistung:
-16.60%
1M Leistung:
-21.87%
6M Leistung:
-24.49%
1J Leistung:
-17.49%
Progyny Inc Stock (PGNY) Company Profile
Firmenname
Progyny Inc
Sektor
Branche
Telefon
212-888-3124
Adresse
1359 BROADWAY, NEW YORK, NY
Compare PGNY vs UNH, CVS, CI, ELV, CNC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
PGNY
Progyny Inc
|
17.79 | 1.51B | 1.13B | 62.75M | 170.92M | 0.63 |
|
UNH
Unitedhealth Group Inc
|
291.96 | 261.98B | 447.57B | 12.81B | 16.08B | 13.19 |
|
CVS
Cvs Health Corp
|
80.57 | 102.40B | 402.11B | 1.73B | 7.81B | 1.3835 |
|
CI
Cigna Group
|
284.74 | 74.81B | 274.88B | 6.29B | 8.39B | 22.19 |
|
ELV
Elevance Health Inc
|
291.45 | 62.69B | 199.13B | 5.66B | 3.17B | 25.11 |
|
CNC
Centene Corp
|
44.99 | 21.55B | 178.19B | 2.05B | 1.08B | 4.0447 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-20 | Hochstufung | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2026-01-08 | Hochstufung | Truist | Hold → Buy |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-11-12 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-07-08 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-12-02 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-11-13 | Herabstufung | Truist | Buy → Hold |
| 2024-09-19 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-08-07 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-08-07 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2024-08-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-07-16 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-05-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-09-27 | Eingeleitet | Canaccord Genuity | Buy |
| 2023-05-22 | Eingeleitet | BTIG Research | Buy |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-05 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-09-07 | Eingeleitet | Truist | Buy |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-11-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-09-30 | Eingeleitet | Berenberg | Buy |
| 2021-08-12 | Eingeleitet | Barclays | Overweight |
| 2021-06-02 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-04-29 | Fortgesetzt | JP Morgan | Overweight |
| 2021-03-10 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-07-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-02 | Eingeleitet | Guggenheim | Buy |
| 2019-11-19 | Eingeleitet | Citigroup | Buy |
| 2019-11-19 | Eingeleitet | Goldman | Buy |
| 2019-11-19 | Eingeleitet | JP Morgan | Overweight |
| 2019-11-19 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-11-19 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Progyny Inc Aktie (PGNY) Neueste Nachrichten
[Form 4] Progyny, Inc. Insider Trading Activity - Stock Titan
Progyny (PGNY) EVP Allison Swartz receives equity grants and sells shares - Stock Titan
Progyny (NASDAQ: PGNY) CEO receives RSUs, options and withholds shares for taxes - Stock Titan
Allison C. Swartz sells shares; PGNY (NASDAQ: PGNY) Form 144 notice - Stock Titan
Progyny: Transitional Headwinds Hide An Undervalued Platform (NASDAQ:PGNY) - Seeking Alpha
Is Progyny (PGNY) Attractive After Recent Share Price Weakness And DCF Upside? - simplywall.st
Progyny, Inc. Hits Day Low of $16.75 Amid Price Pressure - Markets Mojo
Progyny's Valuation Upgrade Reflects Improved Financial Metrics Amid Market Dynamics - Markets Mojo
Progyny, Inc. Hits New 52-Week Low at $16.75 Amid Declining Performance - Markets Mojo
Allison Swartz to sell 4,657 PGNY shares (NASDAQ: PGNY) in vesting sale - Stock Titan
Progyny, Inc. (PGNY) Stock Analysis: Potential 68% Upside with Strong Buy Ratings in Healthcare Sector - DirectorsTalk Interviews
INVO Fertility's Wisconsin Clinic Joins Progyny Network - Bitget
INVO Fertility (IVF) Clinic Joins Progyny Network, Expanding Pat - GuruFocus
INVO Fertility’s Wisconsin Clinic Joins Progyny Network - marketscreener.com
Progyny deal brings INVO fertility care in-network in Wisconsin - Stock Titan
Progyny (PGNY): Truist Securities Lowers Price Target to $28 | P - GuruFocus
JPMorgan Chase & Co. Trims Position in Progyny, Inc. $PGNY - MarketBeat
Intech Investment Management Boosts Progyny Stake by 336% - National Today
Price-Driven Insight from (PGNY) for Rule-Based Strategy - Stock Traders Daily
PGNY (NASDAQ: PGNY) insider sale notice lists 2,199 common shares - Stock Titan
PGNY Sees Revised Price Target Despite Maintained Overweight Rat - GuruFocus
Progyny (NASDAQ:PGNY) Given New $28.00 Price Target at KeyCorp - MarketBeat
KeyBanc lowers Progyny stock price target on conservative estimates By Investing.com - Investing.com Canada
KeyBanc lowers Progyny stock price target on conservative estimates - Investing.com
Vanguard Group Inc. Has $217.48 Million Holdings in Progyny, Inc. $PGNY - MarketBeat
Truist Cuts Price Target on Progyny to $28 From $34, Keeps Buy Rating - marketscreener.com
Truist cuts Progyny stock price target on covered lives miss - Investing.com South Africa
Truist cuts Progyny stock price target on covered lives miss By Investing.com - Investing.com Canada
Intech Investment Management LLC Acquires 130,885 Shares of Progyny, Inc. $PGNY - MarketBeat
Short Interest in Progyny, Inc. (NASDAQ:PGNY) Increases By 41.0% - MarketBeat
Progyny (PGNY) Valuation In Focus After Recent Share Price Weakness - simplywall.st
Progyny, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Progyny (PGNY) Gets a Hold from Canaccord Genuity - The Globe and Mail
Why Progyny (PGNY) Shares Are Trading Lower Today - The Globe and Mail
Decoding Progyny Inc (PGNY): A Strategic SWOT Insight - GuruFocus
Progyny stock hits 52-week low at 17.95 USD By Investing.com - Investing.com Australia
Progyny (NASDAQ:PGNY) Releases Earnings Results, Beats Estimates By $0.10 EPS - MarketBeat
Progyny, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:PGNY) 2026-02-27 - Seeking Alpha
Tranche Update on Progyny, Inc.'s Equity Buyback Plan announced on November 6, 2025. - marketscreener.com
Progyny (NASDAQ:PGNY) Reaches New 1-Year LowTime to Sell? - MarketBeat
Progyny Q4 2025 Earnings: Revenue Beat, Cautious 2026 OutlookNews and Statistics - IndexBox
Progyny stock hits 52-week low at 17.95 USD - Investing.com South Africa
Progyny, Inc. SEC 10-K Report - TradingView
Sector Update: Health Care - marketscreener.com
Progyny (NASDAQ: PGNY) expands women’s health and fertility benefits platform - Stock Titan
Progyny Q4 2025 slides: margin expansion drives earnings beat By Investing.com - Investing.com India
Progyny Q4 Earnings Call Highlights - MarketBeat
Progyny Inc (PGNY) Q4 2025 Earnings Call Highlights: Record Reve - GuruFocus
Earnings call transcript: Progyny Q4 2025 earnings beat expectations By Investing.com - Investing.com India
Progyny, Inc. (PGNY) Q4 2025 Earnings Call Transcript Summary - 富途牛牛
Progyny's (NASDAQ:PGNY) Q4 CY2025: Beats On Revenue - Finviz
Finanzdaten der Progyny Inc-Aktie (PGNY)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):